Healthcare

Insulet sells the Omnipod, a tubeless insulin delivery system that pairs recurring pod revenue with rising adoption in diabetes care. Strong growth, improving margins, and expanding cash flow make the company’s long-term business profile worth a closer look.

Vaxcyte is building next-generation vaccines, with VAX-31 at the center of its push into the large pneumococcal market. The appeal comes from broad product ambition, a focused pipeline, and low debt, making future clinical progress the key factor to watch.

Oscar Health is a digital-first health insurer that has grown rapidly through ACA-focused coverage. Revenue and cash flow have improved sharply, and the company now looks more financially credible, with the big question centered on how durable its margins can become.

Molina Healthcare is a specialized insurer serving Medicaid, Medicare, and ACA Marketplace members. Its appeal rests on scale in government-sponsored coverage, a solid long-term expansion record, and exposure to durable healthcare demand across the U.S.